Home
>
National Drug Code (NDC)
>
RAZADYNE
RAZADYNE - 50458-387-30 - (galantamine hydrobromide)
Drug Information of RAZADYNE
| Product NDC: | 50458-387 |
| Proprietary Name: | RAZADYNE |
| Non Proprietary Name: | galantamine hydrobromide |
| Active Ingredient(s): | 8 mg/1 & nbsp; galantamine hydrobromide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RAZADYNE
| Product NDC: | 50458-387 |
| Labeler Name: | Janssen Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021615 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20041224 |
Package Information of RAZADYNE
| Package NDC: | 50458-387-30 |
| Package Description: | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50458-387-30) |
NDC Information of RAZADYNE
| NDC Code | 50458-387-30 |
| Proprietary Name | RAZADYNE |
| Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50458-387-30) |
| Product NDC | 50458-387 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | galantamine hydrobromide |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20041224 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | GALANTAMINE HYDROBROMIDE |
| Strength Number | 8 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
